Skip to main content

Industry News

  • Sanofi and BioNTech announced that they have entered into a multiyear exclusive collaboration and license agreement. This research collaboration between Sanofi and BioNTech will leverage the scientific expertise of the two organizations to discover and develop up to five cancer immunotherapies, each consisting of a mixture of synthetic messenger RNAs (mRNAs).

  • U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.
    Melanoma, the most aggressive type of skin cancer, is the leading cause of death from skin cancer. Patients with stage III melanoma are generally treated by surgery to remove the melanoma skin lesions and the nearby lymph nodes.

  • Sun Pharmaceutical Industries Ltd.successfully completed cash tender offered by by Thea Acquisition Corp. (“Thea”), an indirect wholly owned subsidiary of Sun Pharma, for all outstanding shares of common stock of InSite Vision Incorporated (OTCBB: INSV, InSite), which expired at 12:00 midnight, New York City time, (the end of the day) on Tuesday, October 27, 2015.

  • 16% local currency operating profit growth adjusted for the NNIT divestment

    Sales increased by 23% in Danish kroner and by 9% in local currencies to DKK 79.1 billion.

    • Sales of Victoza® increased by 39% (21% in local currencies)
    • Sales of Levemir® increased by 27% (10% in local currencies).
    • Sales in North America increased by 33% (10% in local currencies).
    • Sales in International Operations increased by 23% (17% in local currencies).
    • Sales in Region China increased by 26% (5% in local currencies).
  • - 50% of ALF cases happen due to Hepatitis A&E, unavailability of clean potable water

    - ALF mortality has come down to 20 % from 80 % in last 10 years due to advancement in liver intensive care and liver transplantation of ALF patients.

    (NewsVoir); The expert team of Department of Hepatology at Global Hospitals - one of the fastest growing chains of multi-super speciality, multi-organ transplant and quaternary care hospitals in Mumbai, shared their experience in treating and managing Acute Liver Failure patients medically and through transplantation.

    [adsense:336x280:8701650588]

Subscribe to Industry News